Table 3.
Metabolites significantly associated with NDM/LDM and with circulating markers of renal function.
| Vs. BUN | Vs. creatinine | Vs. uric acid | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β ± SE | p-Value | q-Value | p ± SE | p-Value | q-Value | β ± SE | p-Value | q-Value | |
| 2-Hydroxyisobutyrate | 1.8 ± 0.3 | 8.5E − 09 | 4.4E − 07 | 0.0 ± 0.0 | 1.9E − 05 | 0.0002 | 0.0 ± 0.0 | 0.005 | 0.02 |
| Butyrylcarnitine | 0.9 ± 0.3 | 0.002 | 0.01 | 0.0 ± 0.0 | 0.24 | 0.33 | 0.0 ± 0.0 | 0.006 | 0.03 |
| Urea | – | – | – | 0.0 ± 0.0 | 1.6E − 06 | 3.5E − 05 | 0.0 ± 0.0 | 0.005 | 0.02 |
| Pseudouridine | 2.6 ± 0.5 | 2.8E − 06 | 5.1E − 05 | 0.1 ± 0.0 | 5.9E − 12 | 1.7E − 09 | 0.0 ± 0.0 | 2.3E − 06 | 4.5E − 05 |
| N-acetylthreonine | 2.1 ± 0.4 | 5.4E − 07 | 1.7E − 05 | 0.1 ± 0.0 | 9.3E − 10 | 6.5E − 08 | 0.0 ± 0.0 | 0.003 | 0.01 |
| Tiglyl carnitine | 1.4 ± 0.3 | 9.7E − 06 | 0.0001 | 0.0 ± 0.0 | 0.02 | 0.07 | 0.0 ± 0.0 | 0.25 | 0.34 |
| Erythronate | 1.5 ± 0.4 | 0.0001 | 0.0009 | 0.1 ± 0.0 | 4.5E − 12 | 1.6E − 09 | 0.0 ± 0.0 | 0.002 | 0.01 |
| 4-Acetamidobutanoate | 2.0 ± 0.4 | 1.6E − 05 | 0.0002 | 0.1 ± 0.0 | 6.7E − 08 | 2.7E − 06 | 0.0 ± 0.0 | 0.09 | 0.20 |
| Glutamine | − 3.8 ± 0.8 | 1.4E − 05 | 0.0002 | − 0.1 ± 0.0 | 0.0009 | 0.006 | − 0.0 ± 0.0 | 0.0001 | 0.0009 |
| C-glycosyltryptophan | 2.7 ± 0.5 | 6.4E − 07 | 1.8E − 05 | 0.1 ± 0.0 | 2.5E − 10 | 2.4E − 08 | 0.0 ± 0.0 | 0.01 | 0.04 |
| Serine | − 2.1 ± 0.6 | 0.001 | 0.006 | − 0.0 ± 0.0 | 0.01 | 0.05 | − 0.0 ± 0.0 | 0.37 | 0.43 |
| Erythritol | 1.8 ± 0.4 | 8.7E − 06 | 0.0001 | 0.1 ± 0.0 | 7.9E − 10 | 6.4E − 08 | 0.0 ± 0.0 | 0.002 | 0.01 |
| Glutaroyl carnitine | 1.3 ± 0.3 | 8.5E − 05 | 0.0008 | 0.0 ± 0.0 | 0.0002 | 0.002 | 0.0 ± 0.0 | 0.007 | 0.03 |
| Glycoursodeoxycholate | − 0.1 ± 0.1 | 0.41 | 0.44 | − 0.0 ± 0.0 | 0.61 | 0.55 | − 0.0 ± 0.0 | 0.02 | 0.07 |
| Phenylacetylglutamine | 0.7 ± 0.2 | 0.0002 | 0.002 | 0.0 ± 0.0 | 0.0001 | 0.0009 | 0.0 ± 0.0 | 0.03 | 0.09 |
| Dimethylglycine | 0.9 ± 0.4 | 0.02 | 0.06 | 0.0 ± 0.0 | 0.0002 | 0.002 | 0.0 ± 0.0 | 0.0002 | 0.002 |
| 2-Methylbutyroylcarnitine | 1.7 ± 0.4 | 2.5E − 05 | 0.0003 | 0.0 ± 0.0 | 0.0005 | 0.003 | 0.0 ± 0.0 | 0.01 | 0.05 |
| Indolelactate | 1.2 ± 0.3 | 0.0007 | 0.005 | 0.0 ± 0.0 | 0.0001 | 0.0009 | 0.0 ± 0.0 | 0.28 | 0.36 |
| N-acetylalanine | 3.4 ± 0.6 | 8.8E − 07 | 2.2E − 05 | 0.1 ± 0.0 | 4.3E − 11 | 6.1E − 09 | 0.0 ± 0.0 | 0.0002 | 0.002 |
| Methylglutarylcarnitine | 0.3 ± 0.2 | 0.08 | 0.16 | 0.0 ± 0.0 | 0.04 | 0.09 | 0.0 ± 0.0 | 0.49 | 0.49 |
| Octanoylcarnitine | 0.4 ± 0.2 | 0.12 | 0.21 | 0.0 ± 0.0 | 0.06 | 0.13 | 0.0 ± 0.0 | 0.01 | 0.04 |
| Myo-inositol | 2.0 ± 0.3 | 4.1E − 08 | 1.9E − 06 | 0.1 ± 0.0 | 1.9E − 10 | 2.1E − 08 | 0.0 ± 0.0 | 0.0008 | 0.00 |
| Arabitol | 3.3 ± 0.6 | 9.5E − 08 | 3.6E − 06 | 0.1 ± 0.0 | 6.4E − 07 | 1.8E − 05 | 0.0 ± 0.0 | 0.0009 | 0.006 |
| Arabonate | 1.1 ± 0.2 | 2.1E − 05 | 0.000 | 0.0 ± 0.0 | 2.0E − 06 | 4.2E − 05 | 0.0 ± 0.0 | 0.009 | 0.036 |
| Isobutrylcarnitine | 1.2 ± 0.2 | 4.0E − 06 | 6.8E − 05 | 0.0 ± 0.0 | 4.2E − 06 | 7.0E − 05 | 0.0 ± 0.0 | 0.22 | 0.32 |
| Decanoylcarnitine | 0.2 ± 0.3 | 0.34 | 0.41 | 0.0 ± 0.0 | 0.28 | 0.36 | 0.0 ± 0.0 | 0.02 | 0.07 |
| N-formylmethionine | 2.0 ± 0.5 | 2.5E − 05 | 0.0003 | 0.1 ± 0.0 | 1.1E − 09 | 6.9E − 08 | 0.0 ± 0.0 | 0.008 | 0.03 |
| Glycine | − 1.2 ± 0.5 | 0.02 | 0.06 | − 0.0 ± 0.0 | 0.62 | 0.55 | − 0.0 ± 0.0 | 0.0008 | 0.005 |
| Phenol sulfate | 0.5 ± 0.2 | 0.008 | 0.03 | 0.0 ± 0.0 | 0.04 | 0.11 | 0.0 ± 0.0 | 0.05 | 0.12 |
| N1-methyl-2-pyridone-5-carboxamide | 1.3 ± 0.3 | 4.4E − 06 | 7.08E − 05 | 0.0 ± 0.0 | 5.6E − 05 | 0.0006 | 0.0 ± 0.0 | 0.006 | 0.03 |
| Glucuronate | 1.3 ± 0.2 | 4.1E − 07 | 1.36E − 05 | 0.0 ± 0.0 | 0.0003 | 0.002 | 0.0 ± 0.0 | 7.9E − 05 | 0.0008 |
| N-acetylmethionine | 1.0 ± 0.5 | 0.04 | 0.10 | 0.0 ± 0.0 | 0.004 | 0.02 | 0.0 ± 0.0 | 0.21 | 0.31 |
| Deoxycarnitine | − 0.3 ± 0.8 | 0.73 | 0.58 | 0.0 ± 0.0 | 0.008 | 0.03 | − 0.0 ± 0.0 | 0.46 | 0.47 |
| Cis-4-decenoyl carnitine | 0.5 ± 0.3 | 0.10 | 0.19 | 0.0 ± 0.0 | 0.03 | 0.07 | 0.0 ± 0.0 | 0.01 | 0.05 |
| Hexanoylcarnitine | 0.6 ± 0.3 | 0.07 | 0.15 | 0.0 ± 0.0 | 0.11 | 0.21 | 0.0 ± 0.0 | 0.02 | 0.07 |
| Symmetric dimethylarginine | 1.7 ± 0.6 | 0.007 | 0.03 | 0.0 ± 0.0 | 0.003 | 0.02 | 0.0 ± 0.0 | 0.24 | 0.34 |
| N6-acetyllysine | 1.4 ± 0.5 | 0.02 | 0.05 | 0.1 ± 0.0 | 2.2E − 05 | 0.0002 | 0.0 ± 0.0 | 0.02 | 0.07 |
| Trans-urocanate | − 0.8 ± 0.3 | 0.01 | 0.04 | − 0.0 ± 0.0 | 0.12 | 0.22 | − 0.0 ± 0.0 | 0.17 | 0.27 |
| 10-Undecanoate | − 1.0 ± 0.4 | 0.02 | 0.06 | 0.0 ± 0.0 | 0.69 | 0.57 | 0.0 ± 0.0 | 0.82 | 0.61 |
| Threitol | 1.2 ± 0.2 | 4.7E − 06 | 7.3E − 05 | 0.0 ± 0.0 | 1.3E − 11 | 2.4E − 09 | 0.0 ± 0.0 | 0.007 | 0.03 |
| 1-Methylurate | 0.3 ± 0.3 | 0.22 | 0.32 | 0.0 ± 0.0 | 0.03 | 0.08 | 0.0 ± 0.0 | 0.12 | 0.22 |
| N-acetylserine | 1.1 ± 0.4 | 0.01 | 0.04 | 0.0 ± 0.0 | 0.0003 | 0.002 | 0.0 ± 0.0 | 0.03 | 0.08 |
| N1-methyladenosine | 2.4 ± 0.8 | 0.004 | 0.02 | 0.1 ± 0.0 | 2.2E − 06 | 4.4E − 05 | 0.0 ± 0.0 | 0.04 | 0.11 |
Metabolites significantly associated with NDM/LDM and with at least one circulating marker of renal function (BUN, creatinine, uric acid) are shown with parameter estimates and standard errors (β ± SE), and with p- and q-values.